About 6% of people with symptomatic COVID-19 develop long COVID, according to an August 2026 global assessment by the World Health Organization. This post-viral condition encompasses more than 200 symptoms affecting energy, heart health, and cognitive function, with roughly 15% of affected individuals still experiencing symptoms 12 months after their initial infection.
In Plain English: The Clinical Takeaway
- Post-Exertional Malaise (PEM): A severe crash in energy and physical function triggered by everyday effort, typically delayed by 12 to 48 hours.
- Vaccination Benefit: Vaccinated people have roughly 20% to 30% lower risk of long COVID compared with unvaccinated people.
Biological Factors and Persistent Inflammation Markers
There is no single explanation behind long COVID, also known as post-COVID-19 condition or PCC. Majd Alsoubani, MD, MPH, an infectious disease physician at Tufts Medical Center, noted that the condition is likely caused by several biological factors in different people. An April 2024 study published in Nature Immunology found that individuals with long COVID exhibit elevated inflammation markers that persist well beyond their acute illness.
While acute inflammation subsides for most people as they recover from a standard COVID-19 infection, ongoing inflammation may contribute to lingering symptoms like brain fog, headaches, dizziness, and shortness of breath. Alongside immune system activation, Dr. Alsoubani pointed to changes involving blood vessels, the nervous system, metabolism, and the gut microbiome as potential contributors.
Cognitive Impairment and Dopamine System Changes
Neurological and cognitive impacts remain a prominent feature of the condition. A 2026 review of 47 studies involving more than 25,000 people with long COVID estimated that about 30% experienced brain fog, while roughly 25% had cognitive impairment. Yale School of Medicine characterizes these symptoms as a lack of mental clarity, poor focus, memory problems, and difficulty multi-tasking.
To address the physiological roots of these cognitive and energy deficits, a 2026 brain imaging study published in eBioMedicine identified changes in the brain’s dopamine system among patients with long COVID. Dopamine governs motivation, movement, memory, and energy.
Cardiovascular and Respiratory Complications
Lingering physical health impacts extend directly into the cardiovascular and pulmonary systems. A February 2025 meta-analysis published in BMC Medicine, utilizing data from more than 3 million participants, established that individuals with long COVID were significantly more likely to experience chest pain, heart palpitations, and elevated blood pressure compared to uninfected controls. Researchers attribute this to ongoing inflammation and vascular damage.
Furthermore, collaborative research from the Winchester Center for Lung Disease, the Yale Pulmonary Vascular Disease Program, and Brigham and Women’s Hospital demonstrated that recovered patients often suffer a marked reduction in peak oxygen consumption. Even when the heart and lungs function properly on standard tests, their ability to extract and utilize oxygen remains impaired.
| Symptom Category | Estimated Prevalence / Risk | Key Contributing Factor |
|---|---|---|
| Persistent Fatigue | 30% to 65% of patients | Dopamine system alterations & inflammation |
| Brain Fog & Cognitive Issues | 25% to 30% of patients | Neurological & metabolic dysregulation |
| Cardiovascular Abnormalities | Elevated risk vs. uninfected | Vascular tissue damage & immune response |
| Long COVID After Vaccination | 20% to 30% lower risk | Vaccination |
Contraindications & When to Consult a Doctor
Patients experiencing post-exertional malaise should avoid pushing through physical or mental exhaustion, as intense exertion triggers severe symptom crashes. Instead, physicians recommend activity management, or pacing, to stay within an individual’s energy envelope. Anyone noticing new or persistent vision changes should consult an optometrist or ophthalmologist immediately. Professional medical evaluation is also warranted for severe chest pain, worsening shortness of breath, or debilitating cognitive decline that disrupts daily functioning.
While the Centers for Disease Control and Prevention notes that most patients see significant symptom improvement after three months, the WHO estimates that approximately 15% of affected individuals retain symptoms at 12 months.
References
- World Health Organization (WHO). Post COVID-19 condition Fact Sheet.
- World Health Organization (WHO). COVID-19 Global Risk Assessment.
- Nature Immunology. Persistent inflammation markers in long COVID.
- Journal of Clinical Medicine. Post-exertional malaise and energy drop research.
Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
